{"id":1904,"date":"2026-06-10T09:57:08","date_gmt":"2026-06-10T09:57:08","guid":{"rendered":"https:\/\/one-peptides.com\/?p=1904"},"modified":"2026-09-29T16:45:54","modified_gmt":"2026-09-29T16:45:54","slug":"bam-15-what-the-research-says-about-the-mitochondrial-uncoupler-as-an-anti-obesity-candidate","status":"publish","type":"post","link":"https:\/\/one-peptides.com\/de\/bam-15-what-the-research-says-about-the-mitochondrial-uncoupler-as-an-anti-obesity-candidate\/","title":{"rendered":"BAM-15 \u2014 what does the research say about the mitochondrial uncoupler as an anti-obesity candidate?"},"content":{"rendered":"
\n\tHome<\/a>\n<\/span>\u00bb<\/span>\n\tMetabolic research<\/a>\n<\/span>\u00bb<\/span>\n\tBAM-15 \u2014 what does the research say about the mitochondrial uncoupler as an anti-obesity candidate?\n<\/span><\/div><\/div>\n

BAM-15 is a relatively new compound in energy-metabolism research. Metabolic pharmacology has a long and disturbing history with mitochondrial uncouplers. 2,4-dinitrophenol (DNP)<\/strong> was used in the 1930s as a weight-loss drug \u2014 and left a trail of deaths from hyperthermia, cataracts, and multiple organ failure. The Food and Drug Administration withdrew DNP from the market as an anti-obesity drug in 1938.<\/strong> A class of molecules that seemed from a biochemical perspective to be the perfect tool to fight obesity has turned out to be a safety disaster. Despite this, the mechanism of uncoupling oxidative phosphorylation has never ceased to interest scientists – because the problem was not in the idea itself, but in lack of DNP selectivity<\/strong>.<\/p>\n

It is against this background that it appears BAM-15<\/strong> \u2014 a molecule developed in academia in 2014 as an attempt to design a mitochondrially selective, gentle uncoupler<\/strong>. In mouse models it actually shows a promising metabolic and safety profile. However, the data are early, limited almost exclusively to animal models, and the regulatory status is clear: BAM15 is not a drug, is not a dietary supplement, and there are no protocols for its use in humans. In the One Peptides catalog the molecule is available as BAM-15 25 mg<\/a>.<\/p>\n

BAM-15 is a small organic molecule from the class of mitochondrial proton uncouplers (protonophores) – an experimental alternative to the banned DNP, tested in mouse models of obesity, insulin resistance and non-alcoholic fatty liver disease. No registration as a drug, no long-term clinical data in humans.<\/strong><\/p>\n

BAM15 in the One Peptides catalog functions only as chemical reagent intended for laboratory research (Research Use Only)<\/strong>:<\/em><\/p>\n